Copyright Reports & Markets. All rights reserved.

Europe Hemostatic Agents Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Hemostatic Agents Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Oxidized Regenerated Cellulose Market Performance (Volume)
      • 2.1.2 Combination Market Performance (Volume)
      • 2.1.3 Gelatin Market Performance (Volume)
      • 2.1.4 Thrombin Market Performance (Volume)
      • 2.1.5 Collagen Market Performance (Volume)
      • 2.1.6 Other Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Oxidized Regenerated Cellulose Market Performance (Value)
      • 2.2.2 Combination Market Performance (Value)
      • 2.2.3 Gelatin Market Performance (Value)
      • 2.2.4 Thrombin Market Performance (Value)
      • 2.2.5 Collagen Market Performance (Value)
      • 2.2.6 Other Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospitals Market Performance (Volume)
      • 3.1.2 Surgical Centers Market Performance (Volume)
      • 3.1.3 Nursing Homes Market Performance (Volume)
      • 3.1.4 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Baxter International Incorporation
      • 4.1.1 Baxter International Incorporation Profiles
      • 4.1.2 Baxter International Incorporation Product Information
      • 4.1.3 Baxter International Incorporation Hemostatic Agents Business Performance
      • 4.1.4 Baxter International Incorporation Hemostatic Agents Business Development and Market Status
    • 4.2 C.R. Bard Incorporation
      • 4.2.1 C.R. Bard Incorporation Profiles
      • 4.2.2 C.R. Bard Incorporation Product Information
      • 4.2.3 C.R. Bard Incorporation Hemostatic Agents Business Performance
      • 4.2.4 C.R. Bard Incorporation Hemostatic Agents Business Development and Market Status
    • 4.3 B.Braun Melsungen AG
      • 4.3.1 B.Braun Melsungen AG Profiles
      • 4.3.2 B.Braun Melsungen AG Product Information
      • 4.3.3 B.Braun Melsungen AG Hemostatic Agents Business Performance
      • 4.3.4 B.Braun Melsungen AG Hemostatic Agents Business Development and Market Status
    • 4.4 Integra Life Sciences Corporation
      • 4.4.1 Integra Life Sciences Corporation Profiles
      • 4.4.2 Integra Life Sciences Corporation Product Information
      • 4.4.3 Integra Life Sciences Corporation Hemostatic Agents Business Performance
      • 4.4.4 Integra Life Sciences Corporation Hemostatic Agents Business Development and Market Status
    • 4.5 Equimedical
      • 4.5.1 Equimedical Profiles
      • 4.5.2 Equimedical Product Information
      • 4.5.3 Equimedical Hemostatic Agents Business Performance
      • 4.5.4 Equimedical Hemostatic Agents Business Development and Market Status
    • 4.6 Marine Polymer Technologies
      • 4.6.1 Marine Polymer Technologies Profiles
      • 4.6.2 Marine Polymer Technologies Product Information
      • 4.6.3 Marine Polymer Technologies Hemostatic Agents Business Performance
      • 4.6.4 Marine Polymer Technologies Hemostatic Agents Business Development and Market Status
    • 4.7 Gelita GmbH
      • 4.7.1 Gelita GmbH Profiles
      • 4.7.2 Gelita GmbH Product Information
      • 4.7.3 Gelita GmbH Hemostatic Agents Business Performance
      • 4.7.4 Gelita GmbH Hemostatic Agents Business Development and Market Status
    • 4.8 Pfizer Inc
      • 4.8.1 Pfizer Inc Profiles
      • 4.8.2 Pfizer Inc Product Information
      • 4.8.3 Pfizer Inc Hemostatic Agents Business Performance
      • 4.8.4 Pfizer Inc Hemostatic Agents Business Development and Market Status
    • 4.9 Advanced Medical Solutions Group
      • 4.9.1 Advanced Medical Solutions Group Profiles
      • 4.9.2 Advanced Medical Solutions Group Product Information
      • 4.9.3 Advanced Medical Solutions Group Hemostatic Agents Business Performance
      • 4.9.4 Advanced Medical Solutions Group Hemostatic Agents Business Development and Market Status
    • 4.10 Vascular Solutions, Inc
      • 4.10.1 Vascular Solutions, Inc Profiles
      • 4.10.2 Vascular Solutions, Inc Product Information
      • 4.10.3 Vascular Solutions, Inc Hemostatic Agents Business Performance
      • 4.10.4 Vascular Solutions, Inc Hemostatic Agents Business Development and Market Status
    • 4.11 Z-Medica LLC
    • 4.12 Mallinckrodt Plc
    • 4.13 Covidien PLC.
    • 4.14 Atrium Medical Corporation
    • 4.15 Sanofi Group
    • 4.16 Cryolife, Inc.
    • 4.17 Hemostasis, LLC
    • 4.18 Ethicon
    • 4.19 The Medicines Company
    • 4.20 Anika Therapeutics
    • 4.21 Biom'Up SAS
    • 4.22 BioCer Entwicklungs

    5 Market Performance for Manufacturers

    • 5.1 Europe Hemostatic Agents Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Europe Hemostatic Agents Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Europe Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Europe Hemostatic Agents Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Hemostatic Agents Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 Germany Hemostatic Agents Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 Germany Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 Germany Hemostatic Agents Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Hemostatic Agents Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 UK Hemostatic Agents Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 UK Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 UK Hemostatic Agents Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Hemostatic Agents Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 France Hemostatic Agents Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 France Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 France Hemostatic Agents Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Hemostatic Agents Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Russia Hemostatic Agents Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Russia Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Russia Hemostatic Agents Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Hemostatic Agents Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Benelux Hemostatic Agents Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Benelux Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Benelux Hemostatic Agents Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Hemostatic Agents Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 Italy Hemostatic Agents Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 Italy Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 Italy Hemostatic Agents Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Hemostatic Agents Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Spain Hemostatic Agents Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Spain Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Spain Hemostatic Agents Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Hemostatic Agents Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 Hemostatic Agents Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 Hemostatic Agents Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 Hemostatic Agents Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Europe Hemostatic Agents Market Performance (Sales Point)

    • 7.1 Europe Hemostatic Agents Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Europe Hemostatic Agents Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Europe Hemostatic Agents Price (USD/Unit) by Regions 2014-2020
    • 7.4 Europe Hemostatic Agents Gross Margin by Regions 2014-2020

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Hemostatic Agents Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.2 Germany Hemostatic Agents Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.3 UK Hemostatic Agents Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 France Hemostatic Agents Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.5 Russia Hemostatic Agents Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.6 Benelux Hemostatic Agents Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.7 Italy Hemostatic Agents Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.8 Spain Hemostatic Agents Sales and Growth, Sales Value and Growth Rate2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospitals Industry
    • 11.2 Surgical Centers Industry
    • 11.3 Nursing Homes Industry
    • 11.4 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Europe Hemostatic Agents Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Europe Hemostatic Agents Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 Germany Hemostatic Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 UK Hemostatic Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 France Hemostatic Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Russia Hemostatic Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Benelux Hemostatic Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 Italy Hemostatic Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Spain Hemostatic Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Oxidized Regenerated Cellulose Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.3 Combination Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.4 Gelatin Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.5 Thrombin Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.6 Collagen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.7 Other Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.3 Sales Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Hospitals Sales and and Growth Rate 2021-2026
      • 12.3.3 Surgical Centers Sales and and Growth Rate 2021-2026
      • 12.3.4 Nursing Homes Sales and and Growth Rate 2021-2026
      • 12.3.5 Others Sales and and Growth Rate 2021-2026
    • 12.4 Price (USD/Unit) and Gross Profit Forecast
      • 12.4.1 Europe Hemostatic Agents Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Europe Hemostatic Agents Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, our team research the Europe Hemostatic Agents market by type, application, region and manufacturer 2014-2020 and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hemostatic Agents for these regions, from 2014 to 2026 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Hemostatic Agents market competition by top manufacturers/players, with Hemostatic Agents sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Baxter International Incorporation
    C.R. Bard Incorporation
    B.Braun Melsungen AG
    Integra Life Sciences Corporation
    Equimedical
    Marine Polymer Technologies
    Gelita GmbH
    Pfizer Inc
    Advanced Medical Solutions Group
    Vascular Solutions, Inc
    Z-Medica LLC
    Mallinckrodt Plc
    Covidien PLC.
    Atrium Medical Corporation
    Sanofi Group
    Cryolife, Inc.
    Hemostasis, LLC
    Ethicon
    The Medicines Company
    Anika Therapeutics
    Biom'Up SAS
    BioCer Entwicklungs

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Oxidized Regenerated Cellulose
    Combination
    Gelatin
    Thrombin
    Collagen
    Other

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Hemostatic Agents for each application, including
    Hospitals
    Surgical Centers
    Nursing Homes
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now